A high-content phenotypic screen identifies luteolin as a repurposed drug to reduce pyruvate dehydrogenase phosphorylation and enhance energy production in CMTX6 cell models
- J Mol Cell Biol. 2026 Mar 23:mjag012. doi: 10.1093/jmcb/mjag012.
Affiliations
- 1. ANZAC Research Institute, Sydney Local Health District, Concord, NSW 2139, Australia.
- 2. School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2050, Australia.
- 3. Department of Biochemistry, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, Texas 75390-9038, USA.
- 4. Brain and Nerve Research Centre, Concord Repatriation General Hospital, Concord, NSW 2139, Australia.
- 5. Molecular Medicine Laboratory, Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.
PMID: 41871365
DOI: 10.1093/jmcb/mjag012
Products
-
Cat. No.Product NameCategory/Application